Skip to main content
. Author manuscript; available in PMC: 2012 Sep 1.
Published in final edited form as: J Thorac Oncol. 2011 Sep;6(9):1481–1487. doi: 10.1097/JTO.0b013e31822918bd

FIGURE 2.

FIGURE 2

Prediction results of the 91-gene qRT-PCR signature in the 101 samples of validation set. A, Kaplan-Meier survival curve using patient mortality risk index (MRI) from the RSF prediction model built from training set including 91 genes, stage and age. This predictor could significantly separate high, medium and low-risk groups (1/3rd in each group, HR = 1.00, 2.82, 4.42, p = 0.0008) among all 101 patients (A), as well as among the 59 stage 1 patient (1/3rd in each group, HR = 1.00, 3.29, 3.776) (B).